The application of Monide in the preparation of the treatment of osteoarthritis drugs

A technology for osteoarthritis and morroniside, which is applied in the application field of morroniside in the preparation of drugs for treating osteoarthritis, can solve the problem of ineffective utilization of cartilage complete components, disorder of water and salt metabolism and protein metabolism, and synthetic functions. Attenuate and other problems to achieve the effect of attenuating apoptotic activity, slowing damage, and promoting survival

Inactive Publication Date: 2017-07-07
ZHONGSHAN HOSPITAL XIAMEN UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0018] ①Cartilage component supplements: such as glucosamine, hyaluronic acid, etc., due to the decrease in the number of chondrocytes and the weakened synthesis function in osteoarthritis, these cartilage components cannot be effectively used and cannot achieve effective therapeutic effects
[0020] ③ Steroidal anti-inflammatory drugs mainly refer to corticosteroid drugs, because they have a common structural feature, that is, they are all steroids. Although steroidal drugs have excellent anti-inflammatory and analgesic effects, long-term use can cause watery symptoms. Severe disturbance of salt metabolism and sugar, fat, and protein metabolism
However, since it is a joint replacement therapy, the artificial joint metal prosthesis has a certain working life, which is not suitable for young and middle-aged patients and early and middle-term patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The application of Monide in the preparation of the treatment of osteoarthritis drugs
  • The application of Monide in the preparation of the treatment of osteoarthritis drugs
  • The application of Monide in the preparation of the treatment of osteoarthritis drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0075] Some scholars have confirmed that morroniside can protect nerve cells cultured in vitro, so that nerve cells can resist apoptosis caused by adverse environments. Based on the research of these scholars, the present invention cultures human osteoarthritis chondrocytes in vitro, and detects the effect of morroniside on the growth and apoptosis of chondrocytes by cell and molecular biology techniques; and simultaneously detects the main components of the extracellular matrix of chondrocytes Changes in the expression of collagen, proteoglycan Aggrecan, and the expression of some signaling molecules, such as protein kinase B (PKB / Akt) and extracellular regulatory protein kinase (ERK), to understand the effect of morroniside on chondrocytes from the cellular and molecular levels and mechanism. On the other hand, in order to more comprehensively understand the therapeutic effect of morroniside on the cartilage damage of osteoarthritis, the present invention constructs a rat os...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of morroniside to preparation of osteoarthritis treating drugs and relates to application of the morroniside. The morroniside can be used for promoting the in-vitro cultured human osteoarthritis chondrocytes to survive, weakening the chondrocyte index of the chondrocytes, improving the expression levels of II type collagen and proteoglycan Aggrecan in extracellular matrixes of the in-vitro cultured human osteoarthritis chondrocytes, improving the phosphorylation levels of intracellular protein kinase B (PKB / Akt) and extracellular regulated protein kinase of the human osteoarthritis chondrocytes, effectively promoting the survival of the human osteoarthritis chondrocytes and weakening the apoptosis activity of the human osteoarthritis chondrocytes. According to the application, the injury of the osseous tissues in osteoarthritis models of experimental rats is effectively reduced, the cartilage layer thickness is increased and the extracellular polysaccharides content of the cartilage is improved.

Description

technical field [0001] The present invention relates to the application of morroniside, in particular to the application of morroniside in the preparation of medicines for treating osteoarthritis. Background technique [0002] Morroniside is an iridoid glycoside compound extracted from the pulp of Cornus officinalis Sieb.et Zucc at the earliest. Its molecular formula is C17H26O11. For the structural formula, see figure 1 , is one of the active ingredients of the traditional Chinese medicine Liuwei Dihuang Pills. Scholars have recently discovered that it can also be extracted from many medicinal plants such as the stems and leaves of Lonicera macranthoides and the flower buds of Lonicera japonica. [0003] The current research results show that the main pharmacological effects of morroniside include: [0004] 1. Nerve cell protection: protect nerve cells under toxic conditions, or resist the effect of hydrogen peroxide-induced nerve cell apoptosis, so it is mostly used as a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P19/02C07H17/04
Inventor 夏春张兵
Owner ZHONGSHAN HOSPITAL XIAMEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products